Maintenance treatment study designs in bipolar disorder: Do they demonstrate that atypical neuroleptics (antipsychotics) are mood stabilizers?

CNS Drugs

Volumn 25, Issue 10, 2011, Pages 819-827

  Goodwin, Frederick K ^a   Whitham, Elizabeth A ^b   Ghaemi, S Nassir ^b,c  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antipsychotics; Bipolar disorders; Clinical trial design; Maintenance therapy.

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; OLANZAPINE; PLACEBO; QUETIAPINE; RISPERIDONE; VALPROATE SEMISODIUM; ZIPRASIDONE;

BIPOLAR DISORDER; DEPRESSION; HUMAN; HYPOMANIA; MANIA; MONOTHERAPY; PRIORITY JOURNAL; PROPHYLAXIS; RELAPSE; REVIEW; SYSTEMATIC REVIEW; TREATMENT RESPONSE;

AFFECT; ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; HUMANS; MAINTENANCE CHEMOTHERAPY; RECURRENCE; RESEARCH DESIGN;

EID: 80053032908     PISSN: 11727047     EISSN: 11791934     Source Type: Journal    
DOI: 10.2165/11593740-000000000-00000     Document Type: Review

References (28)

1. Goodwin GM, Bowden CL, Calabrese JR, et al. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry 2004 Mar; 65 (3): 432-41
2. Tohen M, Calabrese JR, Sachs GS, et al. Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine. Am J Psychiatry 2006 Feb; 163 (2): 247-56 (Pubitemid 44480844)
3. Keck Jr PE, Calabrese JR, McIntyre RS, et al. Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo. J Clin Psychiatry 2007 Oct; 68 (10): 1480-91 (Pubitemid 350073394)
4. Bowden C, Swann A, Calabrese J, et al. Maintenance clinical trials in bipolar disorder: design implications of the divalproex-lithium-placebo study. Psychopharmacol Bull 1997; 33: 693-9 (Pubitemid 28128124)
5. Calabrese JR, Rapport DJ. Mood stabilizers and the evolution of maintenance study designs in bipolar I disorder. J Clin Psychiatry 1999; 60 Suppl. 5: 5-13, discussion 4-5 (Pubitemid 29164729)
6. Goodwin F, Jamison K. Manic depressive illness. 2nd ed. New York (NY): Oxford University Press, 2007
7. Ghaemi SN. On defining 'mood stabilizer'. Bipolar Disord 2001; 3 (3): 154-8
8. Ayd FJ, editor. Lexicon of psychiatry, neurology, and the neuroscience. Philadelphia (PA): Lippincott, Williams, and Wilkins, 2000
9. Suppes T, Baldessarini RJ, Faedda GL, et al. Risk of reoccurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry 1991; 48: 1082-8
10. Cavanagh J, Smyth R, Goodwin GM. Relapse into mania or depression following lithium discontinuation: a 7-year follow-up. Acta Psychiatr Scand 2004 Feb; 109 (2): 91-5 (Pubitemid 38186819)
11. Tohen M, Frank E, Bowden CL, et al. The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord 2009 Aug; 11 (5): 453-73
12. Bowden C, Calabrese J, McElroy S, et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Arch Gen Psychiatry 2000; 57: 481-9 (Pubitemid 30257262)
13. Bowden C, Calabrese J, Sachs G, et al., Lamictal 606 Study Group. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003; 60: 392-400 (Pubitemid 36403000)
14. Calabrese JR, Bowden CL, Sachs G, et al. A placebocontrolled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 2003 Sep; 64 (9): 1013-24 (Pubitemid 37158246)
15. Calabrese JR, Vieta E, El-Mallakh R, et al. Mood state at study entry as predictor of the polarity of relapse in bipolar disorder. Biol Psychiatry 2004 Dec 15; 56 (12): 957-63 (Pubitemid 39643054)
16. Friedman LM, Furberg CD, DeMets DL. Fundamentals of clinical trials. 3rd ed. New York (NY): Springer-Verlag, 1998
17. Calabrese JR, Goldberg JF, Ketter TA, et al. Recurrence in bipolar I disorder: a post hoc analysis excluding relapses in two double-blind maintenance studies. Biol Psychiatry 2006 Jun 1; 59 (11): 1061-4 (Pubitemid 43849661)
18. Macfadden W, Alphs L, Haskins JT, et al. A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently. Bipolar Disord 2009 Dec; 11 (8): 827-39
19. Quiroz J, Lakshmi Y, Palumbo J, et al. Risperidone longacting injectable monotherapy in the maintenance treatment of bipolar I disorder. Biol Psychiatry 2010; 68: 156-62
20. Pfizer, Data on file, 2010
21. Weisler R, Nolen W, Neijber A, et al. Quetiapine or lithium versus placebo for maintenance treatment of bipolar I disorder after stabilization on quetiapine. 60th Institute on Psychiatric Services Congress; 2008 Oct 2-5; Chicago (IL)
22. Bang H, Davis CE. On estimating treatment effects under non-compliance in randomized clinical trials: are intent-totreat or instrumental variables analyses perfect solutions? Stat Med 2007 Feb 28; 26 (5): 954-64 (Pubitemid 46291124)
23. Tanaka Y,Matsuyama Y, Ohashi Y. Estimation of treatment effect adjusting for treatment changes using the intensity score method: application to a large primary prevention study for coronary events (MEGA study). Stat Med 2008 May 10; 27 (10): 1718-33 (Pubitemid 351566093)
24. Peduzzi P, Detre K, Wittes J, et al. Intent-to-treat analysis and the problem of crossovers: an example from the Veterans Administration coronary bypass surgery study. J Thorac Cardiovasc Surg 1991 Mar; 101 (3): 481-7
25. Deshauer D, Fergusson D, Duffy A, et al. Re-evaluation of randomized control trials of lithium monotherapy: a cohort effect. Bipolar Disord 2005 Aug; 7 (4): 382-7 (Pubitemid 41065240)
26. Geddes JR, Goodwin GM, Rendell J, et al. Lithium plus valproate combination therapy versusmonotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet 2010 Jan 30; 375 (9712): 385-95
27. Briscoe B, El-Mallakh R. The evidence base for the long-term use of antidepressants as prophylaxis against future depressive episodes [poster]. American Psychiatric Association AnnualMeeting; 2010 May 23-26; New Orleans (LA)
28. Amsterdam JD, Shults J. Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study. Am J Psychiatry 2010; 167 (7): 792-800